Search Videos and More
News
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective therapies, we bring hope to patients with serious and debilitating lung diseases.
Course
Diagnosis and Treatment of Obesity-Hypoventilation Syndrome
Obesity hypoventilation syndrome (OHS) is a respiratory disorder resulting in multisystem dysfunction. This program will review the epidemiology, pathophysiology, and mortality of this disorder. Current treatment recommendations as put forth by the American Thoracic Society Assembly on Sleep and Respiratory Neurobiology will be presented, including a comprehensible treatment algorithm.
Video
Bronchoscopic Lung Volume Reduction in Patients with Advanced Emphysema
As part of the Pulmonology On Air 2022 Global Event, Gerard Criner, MD, FACP, FACCP, Director of the Temple Lung Center, demonstrates a LIVE endobronchial valve placement on a patient with advanced homogenous emphysema.
News
GOLD International COPD Conference
Join us in person or online for an international comprehensive educational symposium on chronic obstructive pulmonary disease (COPD). This is the seventh consecutive year for this one-day COPD conference. Wednesday, November 16, 2022 from 8:00 AM – 6:00 PM EST
News
Advanced COPD Fact Sheet
As the nation’s leading COPD research and treatment center, Temple sets new standards for COPD care.
Course
COVID Pneumonia
"COVID pneumonia represents the active inflammation of the pulmonary parenchyma that is caused by SARS-CoV-2, the coronavirus that has caused the COVID-19 pandemic. Millions of patients have been affected worldwide and hospitalizations have occurred all over the globe. The condition can range from mild to severe and represents a challenge for clinicians. Despite the above there is still significant morbidity and mortality associated with COVID pneumonia. It is important for clinicians to recognize this entity, and follow closely the rapidly changing recommendations regarding management and treatment."
Course
Recognizing and Treating Tracheobronchomalacia
"Tracheobronchomalacia (TBM) is an under-recognized cause of shortness of breath, recurrent respiratory infections and chronic coughing. It involves collapse of the main airways, due to a weakness of the cartilage and/or floppiness of the posterior membranous wall. The activity will inform physicians and advanced practitioners about the importance of a multidisciplinary approach in the management of TBM, from diagnosis to treatment. We emphasize the need of reserving surgery to severely symptomatic patients who fail medical therapy, and the importance of objective long-term follow-up of this challenging condition."
Course
GOLD International COPD Conference
Join us in person or online for an international comprehensive educational symposium on chronic obstructive pulmonary disease (COPD). This is the seventh consecutive year for this one-day COPD conference. Wednesday, November 16, 2022 from 8:00 AM – 6:00 PM EST
Document
Advanced Asthma Fact Sheet
While many cases of asthma can be managed in a primary care setting, 5–10% of patients have asthma that cannot be controlled by standard treatments.
Document
Broncoscopic Lung Volume Reduction Physician Fact Sheet
For patients with emphysema and severe hyperinflation whose symptoms cannot be managed using medication or oxygen therapy alone, doctors may resort to surgical resection of the worse regions of emphysema to reduce air trapping and improve patient outcomes
Document
Temple Lung Center Physician Guide
Thanks to our collaboration with physicians like you, we are now one of the largest pulmonary centers in the region (over 32,000 patient visits per year). We also perform 13,000 pulmonary function tests and 1,000 bronchoscopies every year.
News
Lung Transplant Program Referral Information
The Temple Lung Transplant Program is a leader in both quantity and quality. It’s the nation’s highest volume program, but it also has the best one-year survival rates in Philadelphia and all of Pennsylvania.